论文部分内容阅读
目的:探讨肺痿合剂在晚期肺癌姑息治疗中的作用。方法:将2013年1月至2015年12月来我院晚期肺癌科住院治疗的112例晚期姑息治疗的晚期肺癌患者按照随机数字表的分组原则,均分为对照组和观察组,然后针对对照组和观察组分别给予不同的治疗方式。对照组采取常规西药治疗,而观察组则在常规西药治疗的基础上再给予中药肺痿合剂治疗,观察记录两组患者的临床治疗效果。结果:经过1个周期(6周)的治疗显示,观察组的总缓解率明显高于对照组,其两组比较差异有统计学意义(P<0.05);经过2个周期的治疗显示,毒副反应发生率方面,观察组明显低于对照组,其两组比较差异有统计学意义(P<0.05)。结论:肺痿合剂在晚期肺癌姑息治疗中具有积极的作用。
Objective: To investigate the effect of Feiwei Mixture on palliative treatment of advanced lung cancer. Methods: From January 2013 to December 2015, 112 patients with advanced lung cancer hospitalized with advanced palliative care who were admitted to our hospital for advanced lung cancer were divided into control group and observation group according to the principle of grouping by random number table. Group and observation group were given different treatment. The control group to take conventional Western medicine, while the observation group is based on conventional Western medicine and then given the Chinese medicine Hunchia mixture treatment, observe and record the clinical efficacy of two groups of patients. Results: After one cycle (6 weeks) of treatment, the total remission rate of the observation group was significantly higher than that of the control group, the difference between the two groups was statistically significant (P <0.05); after two cycles of treatment showed that the toxicity The incidence of side effects, the observation group was significantly lower than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion: Feiwei Mixture has a positive effect on palliative treatment of advanced lung cancer.